Magnetic resonance‐guided laser interstitial thermal therapy for drug‐resistant epilepsy: A systematic review and individual participant data meta‐analysis
Epilepsia · 2023
DOI: 10.1111/epi.17560 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Epilepsia, 2023. Verfasst von Jia-Shu Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Laser Therapy, Drug Resistant Epilepsy. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Magnetic resonance‐guided laser interstitial thermal therapy (MRgLITT) has emerged as a popular minimally invasive alternative to open resective surgery for drug‐resistant epilepsy (DRE). We sought to perform a systematic review and individual participant data meta‐analysis to identify independent predictors of seizure outcome and complications following MRgLITT for DRE. Eleven databases were searched from January 1, 2010 to February 6, 2021 using the terms “MR‐guided ablation therapy” and “epilepsy”. Multivariable mixed‐effects Cox and logistic regression identified predictors of time to seizure recurrence, seizure freedom, operative complications, and postoperative neurological deficits. From 8705 citations, 46 studies reporting on 450 MRgLITT DRE patients (mean age = 29.5 ± 18.1 years, 49.6% female) were included. Median postoperative seizure freedom and follow‐up duration were 15.5 and 19.0 months, respectively. Overall, 240 (57.8%) of 415 patients (excluding palliative corpus callosotomy) were seizure‐free at last follow‐up. Generalized seizure semiology (hazard ratio [HR] = 1.78, p = .020) and nonlesional magnetic resonance imaging (MRI) findings (HR = 1.50, p = .032) independently predicted shorter time to seizure recurrence. Cerebral cavernous malformation (CCM; odds ratio [OR] = 7.97, p < .001) and mesial temporal sclerosis/atrophy (MTS/A; OR = 2.21, p = .011) were independently associated with greater odds of seizure freedom at last follow‐up. Operative complications occurred in 28 (8.5%) of 330 patients and were independently associated with extratemporal ablations (OR = 5.40, p = .012) and nonlesional MRI studies (OR = 3.25, p = .017). Postoperative neurological deficits were observed in 53 (15.1%) of 352 patients and were independently predicted by hypothalamic hamartoma etiology (OR = 5.93, p = .006) and invasive electroencephalographic monitoring (OR = 4.83, p = .003). Overall, MRgLITT is particularly effective in treating patients with well‐circumscribed lesional DRE, such as CCM and MTS/A, but less effective in nonlesional cases or lesional cases with a more diffuse epileptogenic network associated with generalized seizures. This study identifies independent predictors of seizure freedom and complications following MRgLITT that may help further guide patient selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
- Division of Pediatric Neurosurgery, Department of Surgery, Sainte Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
- Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Division of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
- Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
- Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Jia-Shu Chen, Nathan A Shlobin, George M Ibrahim, Elena Guadagno, Boris C Bernhardt, Aria Fallah, Alexander G Weil
Zitieren
APA
Chen, J. S., Lamoureux, A. A., Shlobin, N. A., Elkaim, L. M., Wang, A., Ibrahim, G. M., Obaid, S., Harroud, A., Guadagno, E., Dimentberg, E., Bouthillier, A., Bernhardt, B. C., Nguyen, D. K., Fallah, A., & Weil, A. G. (2023). Magnetic resonance‐guided laser interstitial thermal therapy for drug‐resistant epilepsy: A systematic review and individual participant data meta‐analysis. Epilepsia. https://doi.org/10.1111/epi.17560
Vancouver
Chen JS, Lamoureux AA, Shlobin NA, Elkaim LM, Wang A, Ibrahim GM, et al. Magnetic resonance‐guided laser interstitial thermal therapy for drug‐resistant epilepsy: A systematic review and individual participant data meta‐analysis. Epilepsia. 2023. doi:10.1111/epi.17560
BibTeX
@article{Chen2023,
author = {Chen, Jia-Shu and Lamoureux, Audrey-Anne and Shlobin, Nathan A and Elkaim, Lior M and Wang, Andrew and Ibrahim, George M and Obaid, Sami and Harroud, Adil and Guadagno, Elena and Dimentberg, Evan and Bouthillier, Alain and Bernhardt, Boris C and Nguyen, Dang K and Fallah, Aria and Weil, Alexander G},
title = {Magnetic resonance‐guided laser interstitial thermal therapy for drug‐resistant epilepsy: A systematic review and individual participant data meta‐analysis},
journal = {Epilepsia},
year = {2023},
doi = {10.1111/epi.17560}
}
EUVIMED